Optometrists in New Smyrna Beach, FL Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Volusia Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: 641 Middlebury Loop, New Smyrna Beach, FL 32168 Phone: 407-353-9656 |
 Charles D Register, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 103 Faulkner St, New Smyrna Beach, FL 32168 Phone: 386-423-7788 Fax: 386-423-0035 |
Beach Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 1928 State Road 44, New Smyrna Beach, FL 32168 Phone: 396-423-7788 Fax: 386-423-0035 |
 Nicola Granger, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 524 Canal St, New Smyrna Beach, FL 32168 Phone: 386-423-5190 |
Chelsea Elyse Heck, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 415 N Causeway, New Smyrna Beach, FL 32169 Phone: 386-427-4143 |
Total Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 330 Canal St, New Smyrna Beach, FL 32168 Phone: 386-423-5190 Fax: 386-423-1490 |
Dr. Phillip Lee Stephens, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 524 Canal St, New Smyrna Beach, FL 32168 Phone: 386-423-5190 Fax: 386-423-1490 |
Myeyedr. Optometrist Medicare: Medicare Enrolled Practice Location: 524 Canal St, New Smyrna Beach, FL 32168 Phone: 386-423-5190 Fax: 386-423-1490 |
News Archive
OMRF receives $14.5 million grant from NIH to continue research on anthrax
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation a five-year, $14.5 million grant to continue its research on anthrax and the bacteria's effects on humans.
Study shows both IDH-mutant WHO-defined molecular subgroups could benefit from PCV chemoradiotherapy
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase 1/2 (IDH) mutation status and 1p/19q co-deletion status represented in the high-risk treatment arms of the NRG Oncology clinical trial NRG-RTOG 9802 indicates that both IDH-mutant sub-groups (IDHmut-noncodel and IDHmut-codel) could benefit from the addition of PCV chemotherapy to radiotherapy treatment.
More children around the world now have allergies and asthma
Researchers in Auckland, New Zealand say that the number of children with allergies and asthma is increasing around the world and especially among the youngest.
Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.
› Verified 1 days ago
Chiropractors
Physical Therapists
Occupational Therapists
Optometrists
Speech-Language Pathologists
Podiatrists
Audiologists